Seeing Is Believing
Currently out of the existing stock ratings of David Rescott, 122 are a BUY (86.52%), 19 are a HOLD (13.48%).
Analyst David Rescott, currently employed at TRUIST, carries an average stock price target met ratio of 60.2% that have a potential upside of 22.79% achieved within 152 days. Previously, David Rescott worked at BAIRD.
David Rescott’s has documented 301 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SIBN, Si-Bone at 14-Oct-2025.
Analyst best performing recommendations are on EW (EDWARDS LIFESCIENCES CORP).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 10/31/2024. The price target of $85 was fulfilled within 5 days with a profit of $12.56 (17.34%) receiving and performance score of 34.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$103
$9.33 (9.96%)
$96
15 days ago
(14-Oct-2025)
14/16 (87.5%)
$7.66 (8.03%)
397
Hold
$105
$11.33 (12.10%)
$87
21 days ago
(08-Oct-2025)
8/16 (50%)
$8.5 (8.81%)
496
Buy
$115
$21.33 (22.77%)
$165
2 months 4 days ago
(25-Aug-2025)
3/7 (42.86%)
$23.51 (25.70%)
555
Buy
$101
$7.33 (7.83%)
$99
2 months 9 days ago
(20-Aug-2025)
8/20 (40%)
$10.59 (11.71%)
657
Buy
$98
$4.33 (4.62%)
$97
2 months 10 days ago
(19-Aug-2025)
3/5 (60%)
$5.48 (5.92%)
261
Which stock is David Rescott is most bullish on?
Which stock is David Rescott is most reserved on?
What Year was the first public recommendation made by David Rescott?